Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CD264 (TRAIL-R4) Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA14298
Description
PA1-4298 detects the TRAIL-Receptor 4 protein in human samples. PA1-4298 has been successfully used in Western blot procedures. PA1-4298 immunogen corresponds to a.a. 57-73 of the mature human TRAIL-R4 protein.
TRAIL (also known as Apo-2L) is a member of the tumor necrosis factor (TNF) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. A fourth member of the emerging TRAIL receptor family, TRAIL-R4, has signaling capacity similar to that of TRAIL-R1 and TRAIL-R2 with respect to NF-kappaB activation, but differs in its inability to induce apoptosis. Like TRAIL-R1 and TRAIL-R2, this receptor shows widespread tissue expression. The human TRAIL-R4 gene has been mapped to chromosome 8p22-21, clustered with three other TRAIL receptors.
Specifications
CD264 (TRAIL-R4) | |
Polyclonal | |
Unconjugated | |
TNFRSF10D | |
CD264; DCR2; Decoy receptor 2; TNF receptor superfamily member 10d; TNF receptor-related receptor for TRAIL; TNF-related apoptosis-inducing ligand receptor 4; TNFRSF10D; TRAIL receptor 4; TRAIL receptor with a truncated death domain; TRAILR4; TRAIL-R4; TRUNDD; Tumor necrosis factor receptor superfamily member 10D; tumor necrosis factor receptor superfamily member 10d, decoy with truncated death domain; tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain; UNQ251/PRO288 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
8793 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 0.02% sodium azide | |
Q9UBN6 | |
TNFRSF10D | |
Synthetic peptide: T(57) I P R Q D E V P Q Q T V A P Q Q(73). | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction